CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 89 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02554656
NCT02554656N/ACompleted

VFEND SPECIAL INVESTIGATION- INVESTIGATION FOR TREATMENT OF INVASIVE FUNGAL INFECTIONS IN PEDIATRIC PATIENTS -

Pfizer·observational·Posted Sep 18, 2015·Updated Apr 14, 2021

In Brief

An observational study for Pediatric Safety and Effectiveness. Completed, enrolled 89 participants across 1 site.

Detailed Summary

Examine the safety and effectiveness of Vfend \[voriconazole\] for pediatric under general clinical practices.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesJapan
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedSep 18, 2015
Enrollment StartOct 27, 2015
Primary CompletionSep 25, 2018
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 10.8 years ago